Trial
NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Harvard Medical School (HMS and HSDM); Commonwealth Research Center, Massachusetts; Novartis
Condition
Schizophrenia
Intervention
Clozapine versus typical (conventional) and atypical antipsychotic medications
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-14